Chitosan Nanoparticles as a Percutaneous Drug Delivery System for Hydrocortisone

<table><i>In-vitro</i> cumulative permeation of HC from (a) QV cream (positive control), (b) aqueous cream (positive control), (c) QV cream containing HC-loaded LMwt CS NPs, and (d) aqueous cream containing HC-loaded LMwt CS NPs at pH 7.4 and 4.0 (<svg height="10.9125" id="M80" style="vertical-align:-0.17555pt" version="1.1" viewbox="0 0 35.099998 10.9125" width="35.099998" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,10.9125)">
<g transform="translate(72,-63.27)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">3</tspan>
</text>
</g>
</g>
</svg>).</table>

Journal of Nanomaterials

fig5

Figure 5

Figure 5: Chitosan Nanoparticles as a Percutaneous Drug Delivery System for Hydrocortisone 